Mon, 27 Dec 2021 China Legal Trends CJO Staff Contributors Team
In November 2021, the Guangzhou Intermediate Court rendered the judgment on the Kangmei Pharmaceutical Co., Ltd. class action case, which marks China’s first securities class action lawsuit, involving more than 50 thousands investors.